Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Delic Holdings Corp DELCF

Delic Holdings Corp. is a Canada-based company. The Company owns and operates a self-sustaining umbrella of businesses in the psychedelic ecosystem consisting of media, science and health. The Company’s subsidiaries include Delic Corp., Delic Labs Inc. (Delic Labs), Ketamine Infusion Centers, LLC (KIC), and Ketamine Wellness Centers, LLC (KWC). Delic Corp. is an international media ecosystem and platform providing information about the psychedelics sector. Delic Labs is a federally licensed cannabis and psilocybin research laboratory focused on extraction optimization, analytical testing, and process development. KWC is the ketamine therapy provider in the United States with approximately 13 clinic locations serving communities across nine states.


GREY:DELCF - Post by User

Post by yopmemama021on May 18, 2021 4:12pm
127 Views
Post# 33223900

DELC.CN

DELC.CN

 $DELC acquisition target CBDV just closed a $3,432,356 private placement.

 

 

The closing of this private placement continues to show shareholders the company’s commitment to expanding the DELIC platform as they move closer towards finalizing the acquisition of CBDV and more. 

 

 

CEO Matt Stang states DELC is “ committed to ensuring the best interests of our shareholders and helping bring greater access to psychedelic wellness to everyone."

 

full news release 

https://finance.yahoo.com/news/delics-acquisition-target-complex-biotech-123000686.html

 

 

DELC at $0.30 , tiny market cap 

<< Previous
Bullboard Posts
Next >>